Roger Lassing

Corporate Officer/Principal at ICONOVO AB

59 year

Health Technology

Commercial Services

Consumer Services

Profile

Roger Lassing is currently the Vice President of Business Development at Iconovo AB.
Previously, he held positions as Vice President at Takeda Pharmaceutical Co., Ltd., Vice President & Global Brand Manager at AstraZeneca AB, and Senior Manager of Global Business Development at LEO Pharma AB.
Lassing received his undergraduate degree and MBA from the University of Lund.

Roger Lassing active positions

Companies	Position	Start
ICONOVO AB	Corporate Officer/Principal	2018-12-31

All active positions of Roger Lassing

Former positions of Roger Lassing

Companies	Position	End
LEO Pharma AB	Corporate Officer/Principal	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	Corporate Officer/Principal	-
AstraZeneca AB AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.	Corporate Officer/Principal	-

See the detail of Roger Lassing's experience

Training of Roger Lassing

University of Lund

Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Roger Lassing's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
ICONOVO AB	Health Technology
TAKEDA PHARMACEUTICAL COMPANY LIMITED	Health Technology

Private companies	2
AstraZeneca AB AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.	Commercial Services
LEO Pharma AB